clinical trials

News

China's Hopstem has been cleared to move straight to a phase 2 trial in the US for its stem cell-based therapy to aid recovery after a stroke.

News

Five-year results with Moderna/MSD's melanoma jab show a 49% reduction in disease progression or death, boding well for phase 3 data later this year.

News

An international trial has started to see if a simple finger-prick blood test could predict Alzheimer's before symptoms start.

News

Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma.

News

New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline.

R&D

The complexity of working with the patient population in obesity continues to challenge traditional trial design. hVIVO looks to the year ahead.